Division of Gastroenterology, Hepatology and Nutrition, Virginia Commonwealth University and McGuire Veterans Affairs Medical Center, Richmond, VA.
Institute of Hepatology, Foundation for Liver Research, London, United Kingdom.
Liver Transpl. 2018 Jun;24(6):752-761. doi: 10.1002/lt.25046. Epub 2018 May 13.
Liver transplantation (LT) improves daily function and ameliorates gut microbial composition. However, the effect of LT on microbial functionality, which can be related to overall patient benefit, is unclear and could affect the post-LT course. The aims were to determine the effect of LT on gut microbial functionality focusing on endotoxemia, bile acid (BA), ammonia metabolism, and lipidomics. We enrolled outpatient patients with cirrhosis on the LT list and followed them until 6 months after LT. Microbiota composition (Shannon diversity and individual taxa) and function analysis (serum endotoxin, urinary metabolomics and serum lipidomics, and stool BA profile) and cognitive tests were performed at both visits. We enrolled 40 patients (age, 56 ± 7 years; mean Model for End-Stage Liver Disease score, 22.6). They received LT 6 ± 3 months after enrollment and were re-evaluated 7 ± 3 months after LT with a stable course. A significant improvement in cognition with increase in microbial diversity, increase in autochthonous and decrease in potentially pathogenic taxa, and reduced endotoxemia were seen after LT compared with baseline. Stool BAs increased significantly after LT, and there was evidence of greater bacterial action (higher secondary, oxo and iso-BAs) after LT although the levels of conjugated BAs remained similar. There was a reduced serum ammonia and corresponding rise in urinary phenylacetylglutamine after LT. There was an increase in urinary trimethylamine-N-oxide, which was correlated with specific changes in serum lipids related to cell membrane products. The ultimate post-LT lipidomic profile appeared beneficial compared with the profile before LT. In conclusion, LT improves gut microbiota diversity and dysbiosis, which is accompanied by favorable changes in gut microbial functionality corresponding to BAs, ammonia, endotoxemia, lipidomic, and metabolomic profiles. Liver Transplantation 24 752-761 2018 AASLD.
肝移植(LT)可改善日常功能并改善肠道微生物组成。然而,LT 对微生物功能的影响(可能与整体患者获益相关)尚不清楚,并且可能会影响 LT 后的病程。本研究旨在确定 LT 对肠道微生物功能的影响,重点关注内毒素血症、胆汁酸(BA)、氨代谢和脂质组学。我们招募了 LT 名单上的肝硬化门诊患者,并在 LT 后 6 个月内对其进行随访。在两次就诊时,均进行了微生物群组成(Shannon 多样性和个体分类群)和功能分析(血清内毒素、尿液代谢组学和血清脂质组学以及粪便 BA 谱)和认知测试。我们共纳入了 40 名患者(年龄 56±7 岁;平均终末期肝病模型评分 22.6)。他们在入组后 6±3 个月接受 LT,并在 LT 后 7±3 个月进行重新评估,此时病程稳定。与基线相比,LT 后认知功能显著改善,微生物多样性增加,原籍和潜在致病分类群减少,内毒素血症减少。LT 后粪便 BA 显著增加,尽管共轭 BA 的水平相似,但细菌作用(更高的二级、氧化和异 BA)增强。LT 后血清氨减少,相应的苯乙酰谷氨酰胺尿增加。尿三甲胺-N-氧化物增加,与细胞膜产物相关的特定血清脂质变化相关。与 LT 前的脂质组学谱相比,LT 后的最终脂质组学谱似乎更有益。总之,LT 可改善肠道微生物多样性和失调,这伴随着肠道微生物功能的有利变化,与 BA、氨、内毒素血症、脂质组学和代谢组学谱相关。肝移植 24 752-761 2018 AASLD。